EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

S100A8/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritis

Meike von Wulffen, Veronika Luehrmann, Stefanie Robeck, Antonella Russo, Lena Fischer-Riepe, Martijn van den Bosch, Peter van Lent, Karin Loser, Dmitry I Gabrilovich, Sven Hermann, Johannes Roth, Thomas Vogl

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.113006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Meike von Wulffen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology, University of Münster, Münster, Germany; Interdisciplinary Center of Clinical Research (IZKF), University of Münster, Münste…. Hauptthemen laut MEDLINE: Arthritis, Myeloid-Derived Suppressor Cells, Calgranulin A, Calgranulin B. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArthritisMyeloid-Derived Suppressor CellsCalgranulin ACalgranulin BAnimalsMiceT-LymphocytesDisease Models, AnimalCell DifferentiationNitric OxideSignal TransductionToll-Like Receptor 4

Stichwörter der Autor:innen

CP: ImmunologyMRP8/MRP14S100A8/S100A9-induced MDSCadoptive transfer of MDSCarthritiscalprotectin

Substanzen

S100a8 protein, mouseS100A9 protein, mouseNitric OxideTlr4 protein, mouseToll-Like Receptor 4Calgranulin ACalgranulin B

Autor:innen und Institutionen

  • Institute of Immunology, University of Münster, Münster, Germany; Interdisciplinary Center of Clinical Research (IZKF), University of Münster, Münster, Germany.
  • Institute of Immunology, University of Münster, Münster, Germany.
  • Department of Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Department of Human Medicine, University of Oldenburg, Oldenburg, Germany.
  • AstraZeneca Oncology R&D, Gaithersburg, MD 20878, USA.
  • European Institute for Molecular Imaging (EIMI), University of Münster, Münster, Germany.

Zitieren

APA

von Wulffen, M., Luehrmann, V., Robeck, S., Russo, A., Fischer-Riepe, L., van den Bosch, M., van Lent, P., Loser, K., Gabrilovich, D. I., Hermann, S., Roth, J., & Vogl, T. (2023). S100A8/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritis. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113006

Vancouver

von Wulffen M, Luehrmann V, Robeck S, Russo A, Fischer-Riepe L, van den Bosch M, et al. S100A8/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritis. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113006

BibTeX
@article{vonWulffen2023,
  author = {von Wulffen, Meike and Luehrmann, Veronika and Robeck, Stefanie and Russo, Antonella and Fischer-Riepe, Lena and van den Bosch, Martijn and van Lent, Peter and Loser, Karin and Gabrilovich, Dmitry I and Hermann, Sven and Roth, Johannes and Vogl, Thomas},
  title = {S100A8/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritis},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.113006}
}
Kostenlos starten →